Article
Low GROa/CXCL1 expression predicts poor outcome and promotes tumour progression in vivo and in vitro, revealing a context-dependent tumour-suppressive role in triple-negative breast cancer
2026-07-02
Abstract excerpt
<title>Abstract</title> <p> Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype with limited treatment options. GROa/CXCL1 is a proinflammatory chemokine that presents high expression levels in TNBC, yet its precise role remains unclear. In this study, GROa/CXCL1 function was studied using TNBC (MDA-MB-231) and luminal (MCF-7) cell lines. GROa/CXCL1 silencing led to a significant in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7f697fb8-6dd9-5a3c-b4ee-7f2ee746f238
- DOI
- 10.21203/rs.3.rs-9982165/v1
